William Cross
- Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme
2024/01/01 by Alona Sosinsky, John C. Ambrose, William Cross +31 · 1 voice · 5 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Genomics and Diagnostics #Pancreatic and Hepatic Oncology Research #Renal cell carcinoma treatment
- PARTY PRIMARIES: TOWARDS A DEFINITION AND TYPOLOGY
2015/04/03 by Ofer Kenig, William Cross, Scott Pruysers +1 · 2 citations
Business, Management and Accounting · Social Sciences · #Electoral Systems and Political Participation #Political Influence and Corporate Strategies #Political Systems and Governance
- Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
2019/09/09 by N.W. Clarke, Amin Ali, A. Ali +90 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer, Lipids, and Metabolism #Prostate Cancer Diagnosis and Treatment #Prostate Cancer Treatment and Research
- Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
2025/07/07 by L.R. Murphy, Nicholas D James, Nicholas D. James +4242 · 1 voice · 2 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Risks and Factors #Cancer, Lipids, and Metabolism #Metabolism, Diabetes, and Cancer
- Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers
2025/08/26 by Emily Grist, Peter Dutey‐Magni, Marina Parry +44 · 1 voice · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Genomics and Diagnostics #Cancer, Lipids, and Metabolism #Prostate Cancer Treatment and Research